Greetings - Oved Daniel and Arieh Kuritzky

Molecular signaling pathways in migraine: update - Messoud Ashina

What to do when nothing works - Alex Mauskop

Variability in migraine epidemiology: lessons learned in southern Israel - Gal Ifergane

Connecting the line between dizziness, occipital headache, muscle tenderness and the cerebellum – Sait Ashina

Open-label studies: do they have any value? - Cristina Tassorelli

Psychedelic compounds for the treatment of headache disorders - Amnon Mosek

Dys-synchronization of alpha waves in migraine with aura: when the entire cortex is disorganized - Oved Daniel

Are there any predictors of response to migraine treatment? - Piero Barbanti

Efficacy of CGRP Modulators in Israel - Real World Data - Roni Sharon

Spontaneous intracranial hypotension - an update on diagnosis and management - Abraham Ashkenazi

Targeting CGRP receptor vs. ligand - which option is efficacious and safer in Migraine prevention? Nirit Lev

Differences and similarities between CGRP-mAbs and small molecule CGRP antagonists - Rami Burstein

A new era in the acute care and prevention of migraine - Alan Rapoport

Impact of anti-CGRP in patients with migraine: what the eye can’t see - Patricia Pozo Rosich

Open Discussion/Debate - All speakers

הירשמו לקבלת עדכונים בנושאים שעלו בכתבה